基本信息
浏览量:83
职业迁徙
个人简介
Dr. Wise Young, founding director of the W. M. Keck Center for Collaborative Neuroscience and a distinguished professor, is recognized as one of the world's outstanding neuroscientists.
Dr. Young is committed to bringing treatments to people with spinal cord Injuries. He built and trained a twenty-five center clinical trial network in China, Taiwan, and Hong Kong where human clinical trials using umbilical cord blood mononuclear cells and lithium are underway. In the initial results from the Phase II trial in Kunming, China, 75% of the participants (15 out of 20) recovered walking with a rolling walker. He is establishing clinical trial networks in the United States, Norway, and India and will start Phase IIB Trials in 2016 and Phase III trials in 2017.
Dr. Young is committed to bringing treatments to people with spinal cord Injuries. He built and trained a twenty-five center clinical trial network in China, Taiwan, and Hong Kong where human clinical trials using umbilical cord blood mononuclear cells and lithium are underway. In the initial results from the Phase II trial in Kunming, China, 75% of the participants (15 out of 20) recovered walking with a rolling walker. He is establishing clinical trial networks in the United States, Norway, and India and will start Phase IIB Trials in 2016 and Phase III trials in 2017.
研究兴趣
论文共 210 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
crossref(2023)
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESno. 18 (2023): 14271-14271
crossref(2023)
Hadi Askarifirouzjaei,Leila Khajoueinejad,Elena Wei, Sruti Cheruvu,Carlos Ayala, Ning Chiang,Thomas Theis,Dongming Sun,Mehdi Fazeli,Wise Young
Pathophysiology : the official journal of the International Society for Pathophysiologyno. 3 (2023): 275-295
crossref(2023)
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEno. 8 (2023)
引用0浏览0引用
0
0
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn